Literature for peptidase S01.278: HtrA2 peptidase

(References are filtered for relevance to Target. To remove the filter click here. See explanation.)

2016
1. Gibellini,L., DeBiasi,S., Nasi,M., Iannone,A., Cossarizza,A. and Pinti,M.
   Mitochondrial proteases as emerging pharmacological targets
   Curr Pharm Des22, 2679-2688. PubMed  Europe PubMed  T
2010
2. Chien,J.
   WT1 as a substrate of HtrA2: a potential pathway for therapeutic targeting by HtrA proteases
   Future Oncol6, 1233-1235. PubMed  Europe PubMed DOI  T
2009
3. Bhuiyan,M.S. and Fukunaga,K.
   Mitochondrial serine protease HtrA2/Omi as a potential therapeutic target
   Curr Drug Targets10, 372-383. PubMed  Europe PubMed DOI  V  T
4. Chien,J., Campioni,M., Shridhar,V. and Baldi,A.
   HtrA serine proteases as potential therapeutic targets in cancer
   Curr Cancer Drug Targets9, 451-468. PubMed  Europe PubMed DOI  T
2007
5. Althaus,J., Siegelin,M.D., Dehghani,F., Cilenti,L., Zervos,A.S. and Rami,A.
   The serine protease Omi/HtrA2 is involved in XIAP cleavage and in neuronal cell death following focal cerebral ischemia/reperfusion
   Neurochem Int50, 172-180. PubMed  Europe PubMed DOI  T  I